Published in J Pharmacol Exp Ther on March 01, 1999
Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell (2011) 2.13
Mu opioids and their receptors: evolution of a concept. Pharmacol Rev (2013) 1.66
Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr Biol (2008) 1.44
Revisiting the isobole and related quantitative methods for assessing drug synergism. J Pharmacol Exp Ther (2012) 1.20
Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis. Pharmacol Ther (2009) 1.15
Synergistic interaction between the two mechanisms of action of tapentadol in analgesia. J Pharmacol Exp Ther (2011) 1.10
Quantitative methods for assessing drug synergism. Genes Cancer (2011) 1.06
p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons. J Biol Chem (2009) 0.97
Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray. Neuropharmacology (2007) 0.95
The relationship between resting blood pressure and acute pain sensitivity: effects of chronic pain and alpha-2 adrenergic blockade. J Behav Med (2007) 0.86
Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects. PLoS One (2014) 0.84
Analgesic synergy between opioid and α2 -adrenoceptors. Br J Pharmacol (2014) 0.81
Protein kinase Cε is required for spinal analgesic synergy between delta opioid and alpha-2A adrenergic receptor agonist pairs. J Neurosci (2013) 0.81
A comparative study of magnesium sulfate vs dexmedetomidine as an adjunct to epidural bupivacaine. J Anaesthesiol Clin Pharmacol (2014) 0.80
Influence of clonidine and ketamine on m-RNA expression in a model of opioid-induced hyperalgesia in mice. PLoS One (2013) 0.79
Morphine and clonidine synergize to ameliorate low back pain in mice. Pain Res Treat (2012) 0.78
μ-Opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neurons. Br J Pharmacol (2014) 0.78
Heterologous regulation of Mu-opioid (MOP) receptor mobility in the membrane of SH-SY5Y cells. J Biol Chem (2014) 0.76
Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance. Br J Pharmacol (2008) 0.76
Comparison between paracetamol, piroxicam, their combination, and placebo in postoperative pain management of upper limb orthopedic surgery (a randomized double blind clinical trial). Adv Biomed Res (2016) 0.75
Evaluation of bupivacaine-clonidine combination for unilateral spinal anesthesia in lower limb below-knee orthopedic surgery. Saudi J Anaesth (2014) 0.75
Comparison of two different doses of intrathecal dexmedetomidine as adjuvant with isobaric ropivacaine in lower abdominal surgery. Anesth Essays Res (2015) 0.75
Intrathecal morphine in mice: a new technique. Eur J Pharmacol (1980) 5.99
Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg (1989) 1.96
Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res (1981) 1.61
Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci (2001) 1.50
Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J Pharmacol Exp Ther (1987) 1.42
Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. J Neurosci (1998) 1.40
The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci (1997) 1.37
The role of nitric oxide in hippocampal long-term potentiation. Neuron (1992) 1.33
Cytokine involvement in dynorphin-induced allodynia. Pain (2000) 1.29
Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. J Neurosci (1991) 1.27
Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett (1992) 1.24
Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. J Neurosci (2001) 1.24
Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain (1996) 1.22
Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain (1997) 1.18
Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A (2000) 1.14
Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2. Neuroreport (1997) 1.04
Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther (1987) 1.03
Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level. J Pharmacol Exp Ther (1983) 1.00
Mechanisms of induction of persistent nociception by dynorphin. J Pharmacol Exp Ther (2001) 1.00
Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord. Brain Res (1987) 1.00
Intrathecal substance P and somatostatin in rats: behaviors indicative of sensation. Peptides (1982) 0.99
Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice. Neuroscience (2005) 0.96
An instrument using a multiple layer Peltier device to change skin temperature rapidly. Brain Res Bull (1984) 0.95
Functional interactions between tumor and peripheral nerve in a model of cancer pain in the mouse. Pain Med (2001) 0.93
Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther (1997) 0.93
Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites. Brain Res (1984) 0.93
A nitric oxide synthesis inhibitor (L-NAME) reduces licking behavior and Fos-labeling in the spinal cord of rats during formalin-induced inflammation. Pain (1996) 0.93
Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors. J Pharmacol Exp Ther (1992) 0.92
Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport (2000) 0.92
Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice. Neurosci Lett (1986) 0.92
Effects of peripheral nerve injury on alpha-2A and alpha-2C adrenergic receptor immunoreactivity in the rat spinal cord. Neuroscience (1999) 0.90
Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther (1993) 0.90
Intrathecal serotonin in mice: analgesia and inhibition of a spinal action of substance P. Life Sci (1983) 0.90
Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain (1990) 0.89
Analgesic properties of intrathecally administered heterocyclic antidepressants. Pain (1987) 0.87
Intrathecal opioids block a spinal action of substance P in mice: functional importance of both mu- and delta-receptors. Eur J Pharmacol (1982) 0.87
Neurogenesis in postnatal rat spinal cord: a study in primary culture. Science (1997) 0.86
Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. J Pharmacol Exp Ther (1999) 0.85
Nitric oxide mediates Fos expression in the spinal cord induced by mechanical noxious stimulation. Neuroreport (1992) 0.85
Baclofen, gamma-aminobutyric acidB receptors and substance P in the mouse spinal cord. J Pharmacol Exp Ther (1989) 0.84
Moxonidine, a selective imidazoline-alpha2 -adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice. Anesthesiology (2000) 0.84
Differential effects of spinal cord lesions on narcotic and non-narcotic suppression of nociceptive reflexes: further evidence for the physiologic multiplicity of pain modulation. Brain Res (1978) 0.82
Functional expression of adrenergic and opioid receptors in Xenopus oocytes: interaction between alpha 2- and beta 2-adrenergic receptors. Brain Res Mol Brain Res (1995) 0.82
Muscimol, gamma-aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord. J Pharmacol Exp Ther (1989) 0.81
Analgesic synergy between opioid and α2 -adrenoceptors. Br J Pharmacol (2014) 0.81
Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance. J Neurosci (1994) 0.80
Spinal plasticity of acute opioid tolerance. J Biomed Sci (2000) 0.80
Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors. Eur J Pharmacol (1993) 0.79
Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice. J Pharmacol Exp Ther (1991) 0.79
Modeling motor cortical operations by an attractor network of stochastic neurons. Biol Cybern (1996) 0.79
Enhancement of NMDA-evoked neuronal activity by glycine in the rat spinal cord in vivo. Neurosci Lett (1992) 0.79
Immunofluorescence analysis of antisense oligodeoxynucleotide-mediated 'knock-down' of the mouse delta opioid receptor in vitro and in vivo. Neurosci Lett (1996) 0.79
Synergistic behavioral effects of serotonin and tryptamine injected intrathecally in mice. Neuropharmacology (1984) 0.78
Intradermal hypertonic saline-induced behavior as a nociceptive test in mice. Life Sci (1986) 0.78
Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors. Br J Pharmacol (2014) 0.77
Effects of nitric oxide availability on responses of spinal wide dynamic range neurons to excitatory amino acids. Eur J Pharmacol (1995) 0.77
Overlapping neural networks for multiple motor engrams. Proc Natl Acad Sci U S A (1994) 0.77
Modulation of N-methyl-D-aspartate and (R,S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) responses of spinal nociceptive neurons by a N-terminal fragment of substance P. Eur J Pharmacol (1992) 0.77
Redox manipulation of NMDA receptors in vivo: alteration of acute pain transmission and dynorphin-induced allodynia. Pain (1999) 0.77
Antinociceptive effect of morphine on rat spinothalamic tract and other dorsal horn neurons. Neuroscience (1986) 0.77
Anti-nociceptive effect of tricyclic anti-depressants following intrathecal administration. Anesth Prog (1985) 0.77
Antinociception following implantation of AtT-20 and genetically modified AtT-20/hENK cells in rat spinal cord. J Neural Transplant Plast (1994) 0.76
mu-opioid receptor regulates CFTR coexpressed in Xenopus oocytes in a cAMP independent manner. Brain Res Mol Brain Res (1997) 0.76
Antinociception following implantation of mouse B16 melanoma cells in mouse and rat spinal cord. Pain (1994) 0.75
Antinociceptive action of intrathecal neurotensin in mice. Peptides (1984) 0.75
An iconographic program for computer-controlled whole-cell voltage clamp experiments. J Neurosci Methods (1993) 0.75
Opioid and neurokinin activities of substance P fragments and their analogs. Eur J Pharmacol (1991) 0.75
Tail pinch induced consummatory behaviors are associated with analgesia. Physiol Behav (1982) 0.75
A renumbering method to decrease matrix banding in equations describing branched neuron-like structures. J Neurosci Methods (1996) 0.75
Correlates of nociception and antinociception in dorsal root potentials in the rat. Neuropharmacology (1982) 0.75
New xenograft model for assessing experimental therapy of central nervous system tumors: human glioblastoma in the intrathecal compartment of the nude mouse. Neurosurgery (1988) 0.75
Cycloheximide effects on electroencephalographic and evoked responses in mice. Behav Biol (1974) 0.75